In the last few years, it has been demonstrated by this group and others that rat liver peroxisomes participate in cholesterol synthesis. Peroxisomes contain the following enzymes and proteins involved in cholesterol synthesis: 1) 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme of cholesterol synthesis; 2) the thiolase activity necessary for the initial step in cholesterol synthesis; and 3) cellular sterol carrier protein 2 (SCP-2), a protein required for several steps in cholesterol utilization and biosynthesis. In addition, peroxisomes can convert mevalonic acid to cholesterol in the presence of cytosolic proteins. These unexpected findings raise interesting questions about the characteristics of the proteins involved in peroxisomal cholesterol synthesis, the fate of peroxisome-synthesized cholesterol, and the regulation and function of the peroxisomal system. This proposal will focus on the following: 1. Purification of peroxisomal HMG-CoA reductase and production of polyclonal and monoclonal antibodies that are specific for the peroxisomal reductase; 2. Cloning of the cDNA for the rat and/or mouse peroxisomal HMG-CoA reductase and determination of its nucleotide sequence; 3. Cloning of the human peroxisomal HMG-CoA reductase cDNA. We have shown that the peroxisomal HMG-CoA reductase constitutes the majority of the immunoreactive material in the human hepatoma cell line HepG2; 4. Analysis of the regulation of the peroxisomal HMG-CoA reductase. Since peroxisomes are essential for life, and have also been shown to be involved in cholesterol metabolism, it is critical to obtain answers to the following questions. What is the structure of the peroxisomal HMG-CoA reductase and how is it regulated? What is the significance of the cholesterol synthesis system in peroxisomes? What is the pathway of peroxisomal cholesterol synthesis? What is the fate of the cholesterol synthesized by peroxisomes: is it used for bile acid synthesis, steroid hormone synthesis, vitamin D, or lipoproteins? Does peroxisomal cholesterol synthesis occur in tissues other than the liver? Only a systematic study of the proteins involved in cholesterol synthesis in peroxisomes will begin to answer the above questions. It is essential to understand the function of the peroxisomal reductase and the fate of the cholesterol synthesized by peroxisomes before we can begin to assess the significance and the role of peroxisomal cholesterol synthesis in regulation of total cholesterol homeostasis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032852-10
Application #
2138892
Study Section
Metabolism Study Section (MET)
Project Start
1983-08-01
Project End
1997-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
San Diego State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
073371346
City
San Diego
State
CA
Country
United States
Zip Code
92182
Aboushadi, N; Shackelford, J E; Jessani, N et al. (2000) Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition. Biochemistry 39:237-47
Olivier, L M; Chambliss, K L; Gibson, K M et al. (1999) Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. J Lipid Res 40:672-9
Aboushadi, N; Krisans, S K (1998) Analysis of isoprenoid biosynthesis in peroxisomal-deficient Pex2 CHO cell lines. J Lipid Res 39:1781-91
Engfelt, W H; Masuda, K R; Paton, V G et al. (1998) Splice donor site mutations in the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene cause a deficiency of the endoplasmic reticulum 3-hydroxy-3-methylglutaryl coenzyme A reductase protein in UT2 cells. J Lipid Res 39:2182-91
Engfelt, W H; Shackelford, J E; Aboushadi, N et al. (1997) Characterization of UT2 cells. The induction of peroxisomal 3-hydroxy-3-methylglutaryl-coenzyme a reductase. J Biol Chem 272:24579-87
Paton, V G; Shackelford, J E; Krisans, S K (1997) Cloning and subcellular localization of hamster and rat isopentenyl diphosphate dimethylallyl diphosphate isomerase. A PTS1 motif targets the enzyme to peroxisomes. J Biol Chem 272:18945-50
Westfall, D; Aboushadi, N; Shackelford, J E et al. (1997) Metabolism of farnesol: phosphorylation of farnesol by rat liver microsomal and peroxisomal fractions. Biochem Biophys Res Commun 230:562-8
Krisans, S K (1996) Cell compartmentalization of cholesterol biosynthesis. Ann N Y Acad Sci 804:142-64
Biardi, L; Krisans, S K (1996) Compartmentalization of cholesterol biosynthesis. Conversion of mevalonate to farnesyl diphosphate occurs in the peroxisomes. J Biol Chem 271:1784-8
Biardi, L; Sreedhar, A; Zokaei, A et al. (1994) Mevalonate kinase is predominantly localized in peroxisomes and is defective in patients with peroxisome deficiency disorders. J Biol Chem 269:1197-205

Showing the most recent 10 out of 19 publications